Article
Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia--neonatal and infantile course.
European journal of pediatrics - 1 Jul 1994
Artlich A, Möller J, Tschakaloff A, Schwinger E, Kruse K, Gortner L
Abstract excerpt
Experience with the use of cytotoxic drugs in the first trimester of pregnancy is limited. We report on the clinical phenotype and infantile development of a girl born to a 36-year-old mother. Before recognition of pregnancy, the latter had been treated for acute myelocytic leukaemia receiving cytarabine, daunorubicin and doxorubicin at conception and cytarabine and thioguanine at about 35-37 days post...
Topics
- Abnormalities, Drug-Induced
- Adult
- Antineoplastic Combined Chemotherapy Protocols
- Arm
- Craniosynostoses
- Cytarabine
- Daunorubicin
- Doxorubicin
- Female
- Humans
- Infant, Newborn
